Zhong Y - Search Results

1

Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.

Li S, Zhou Y, Lu W, Zhong Y, Song W, Liu K, Huang J, Zhao Z, Xu Y, Liu X, Li H. Li S, et al. Among authors: zhong y. J Chem Inf Model. 2011 Nov 28;51(11):2939-47. doi: 10.1021/ci2002445. Epub 2011 Oct 21. J Chem Inf Model. 2011. PMID: 21995341

2

Selective and sensitive detection and quantification of arylamine N-acetyltransferase 2 by a ratiometric fluorescence probe.

Cui L, Zhong Y, Zhu W, Xu Y, Qian X. Cui L, et al. Among authors: zhong y. Chem Commun (Camb). 2010 Oct 14;46(38):7121-3. doi: 10.1039/c0cc01000f. Epub 2010 Aug 26. Chem Commun (Camb). 2010. PMID: 20798904

3

A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.

Cui L, Zhong Y, Zhu W, Xu Y, Du Q, Wang X, Qian X, Xiao Y. Cui L, et al. Among authors: zhong y. Org Lett. 2011 Mar 4;13(5):928-31. doi: 10.1021/ol102975t. Epub 2011 Jan 26. Org Lett. 2011. PMID: 21268631

4

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.

Xue M, Cao X, Zhong Y, Kuang D, Liu X, Zhao Z, Li H. Xue M, et al. Among authors: zhong y. Curr Pharm Des. 2012;18(20):2901-13. doi: 10.2174/138161212800672723. Curr Pharm Des. 2012. PMID: 22571659 Review.

5

Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.

Zhong Y, Xue M, Zhao X, Yuan J, Liu X, Huang J, Zhao Z, Li H, Xu Y. Zhong Y, et al. Bioorg Med Chem. 2013 Apr 1;21(7):1724-34. doi: 10.1016/j.bmc.2013.01.047. Epub 2013 Jan 30. Bioorg Med Chem. 2013. PMID: 23434140

6

Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity Evaluation.

Zhong Y, Xu J, Zhou R, Tang L, Ding S, Ren Z, Song N, Hu B, Yang H, Sun Y, Cheng M, Li J, Liu Y. Zhong Y, et al. J Med Chem. 2024 Mar 28;67(6):4739-4756. doi: 10.1021/acs.jmedchem.3c02329. Epub 2024 Mar 15. J Med Chem. 2024. PMID: 38488882

7

Discovery of novel CDK9 inhibitor with tridentate ligand: Design, synthesis and biological evaluation.

Zhong Y, Xu J, Ding S, Cao H, Zhang Y, Hu B, Han S, Yang H, Cheng M, Li J, Sun Y, Liu Y. Zhong Y, et al. Bioorg Chem. 2024 Sep;150:107550. doi: 10.1016/j.bioorg.2024.107550. Epub 2024 Jun 10. Bioorg Chem. 2024. PMID: 38878756

8

Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.

Zhong Y, Li ZN, Jiang XY, Tian X, Deng MH, Cheng MS, Yang HL, Liu Y. Zhong Y, et al. Int J Mol Sci. 2022 Dec 12;23(24):15768. doi: 10.3390/ijms232415768. Int J Mol Sci. 2022. PMID: 36555409 Free PMC article.

9

Synthesis and Antitumor Activity Evaluation of Novel Echinatin Derivatives with a 1,3,4-Oxadiazole Moiety.

Tian X, Sun Z, Zhong Y, Yang H, Cheng M, Liu Y. Tian X, et al. Among authors: zhong y. Int J Mol Sci. 2024 Feb 13;25(4):2254. doi: 10.3390/ijms25042254. Int J Mol Sci. 2024. PMID: 38396931 Free PMC article.

10

Synthesis, Molecular Docking Analysis, and Biological Evaluations of Saccharide-Modified Sulfonamides as Carbonic Anhydrase IX Inhibitors.

Zhang Z, Yang H, Zhong Y, Wang Y, Wang J, Cheng M, Liu Y. Zhang Z, et al. Among authors: zhong y. Int J Mol Sci. 2021 Dec 19;22(24):13610. doi: 10.3390/ijms222413610. Int J Mol Sci. 2021. PMID: 34948406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,882 results

Search Page

Filters